Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ataxin-1-like pseudogene (ENSG00000271573) is a nonfunctional DNA sequence in the human genome that shows sequence similarity to the ataxin-1 gene but contains mutations or structural changes (such as premature stop codons, deletions, or frameshifts) that prevent it from encoding a functional protein. Pseudogenes such as this are considered genomic relics generated by duplication or retrotransposition events and typically do not have established protein products or direct roles in disease. While many pseudogenes are biologically inert, some may exert regulatory effects on expression of homologous genes, though no readily available evidence points to a direct functional or disease association for this specific pseudogene. It is not considered a valid therapeutic target, nor are drugs or biomarkers developed against it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ataxin-1-like pseudogene.